| |
|
|
|
Azurrx Biopharma Inc  
|
|
2.5 0.04 (0.02%) |
05-25 16:00 |
|
Open: |
2.5001 |
Pre close: |
2.46 |
Target:
|
3.71 
|
|
High: |
2.51 |
Low: |
2.39 |
Resistance:
|
3.18
3.67
|
|
Volume: |
47,380 |
Market Cap: |
42M |
Support:
|
2.38
1.98
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.49
|
MACD |
MACD(12,26):
|
-0.13  |
|
MA(20): |
2.60 |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
3.03 |
Stochastic Oscillator |
%K(14,3):
|
24.48 |
|
MA(250): |
3.38 |
%D(3): |
22.16 |
|
Average Volume(K) |
3-Month: |
3387
|
52-Week |
High:
|
5.25 |
|
10-Days: |
2815 |
Low: |
2.31 |
|
RSI |
RSI(14):
|
40.78 |
Change(%): |
-32.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.570 |
Return on Equity (ttm) |
-455.4 |
Shares Out. (M) |
16.76 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-181.4 |
Shares Float (M) |
16.22 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.30 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
21.50 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
40 |
|
Book Value (p.s.) |
25.940 |
EBITDA (p.s.) |
-0.439 |
P/E |
-4.39 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.10 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.18 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.42 |
P/CF |
-5.84 |
|
|
|
|
|
|
